The GPER1 agonist G-1 attenuates endothelial cell proliferation by inhibiting DNA synthesis and accumulating cells in the S and G2 phases of the cell cycle

Journal of Vascular Research

Volumn 48, Issue 4, 2011, Pages 327-335

  Holm, Anders ^a   Baldetorp, Bo ^b   Olde, Björn ^a   Leeb Lundberg, L M Fredrik ^a   Nilsson, Bengt Olof ^a  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Cell cycle; DNA synthesis; Endothelial cells; Estrogen; Estrogen receptor; G 1; GPER1

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CHEMOKINE RECEPTOR AGONIST; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; G 1; MESSENGER RNA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL STRAIN COS7; CONTROLLED STUDY; DNA SYNTHESIS INHIBITION; IC 50; IMMUNOREACTIVITY; MICROVASCULAR ENDOTHELIAL CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UMBILICAL VEIN ENDOTHELIAL CELL;

ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; COS CELLS; CYCLOPENTANES; DNA; ENDOTHELIAL CELLS; G2 PHASE; HUMANS; MICE; QUINOLINES; RECEPTORS, ESTROGEN; RECEPTORS, G-PROTEIN-COUPLED; S PHASE;

EID: 79151480468     PISSN: 10181172     EISSN: 14230135     Source Type: Journal    
DOI: 10.1159/000322578     Document Type: Article

References (39)

1. Mendelsohn ME, Karas RH: The protective effects of estrogen on the cardiovascular system. N Engl J Med 1999;340:1801-1811. (Pubitemid 29266405)
2. Stampfer M, Grodstein F: Cardioprotective effect of hormone replacement therapy is not due to selection bias. BMJ 1994;309:808-809. (Pubitemid 24291672)
3. Nathan L, Pervin S, Singh R, Rosenfeld M, Chaudhuri G: Estradiol inhibits leukocyte adhesion and transendothelial migration in rabbits in vivo: possible mechanisms for gender differences in atherosclerosis. Circ Res 1999;85:377-385. (Pubitemid 29398870)
4. Nilsson BO: Modulation of the inflammatory response by estrogens with focus on the endothelium and its interactions with leukocytes. Inflamm Res 2007;56:269-273.
5. Chen Z, Yuhanna IS, Galcheva-Gargova Z, Karas RH, Mendelsohn ME, Shaul PW: Estrogen receptor alpha mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J Clin Invest 1999;103:401-406. (Pubitemid 29069990)
6. Pare G, Krust A, Karas RH, Dupont S, Aronovitz M, Chambon P, Mendelsohn ME: Estrogen receptor-α mediates the protective effects of estrogen against vascular injury. Circ Res 2002;90:1087-1092. (Pubitemid 34627907)
7. Brouchet L, Krust A, Dupont S, Chambon P, Bayard F, Arnal JF: Estradiol accelerates re-endothelialization in mouse carotid artery through estrogen receptor-α but not estrogen receptor-α. Circulation 2001;103:423-428. (Pubitemid 32105983)
8. Krasinski K, Spyridopoulos I, Asahara T, van der Zee R, Isner JM, Losordo DW: Estradiol accelerates functional endothelial recovery after arterial injury. Circulation 1997;95:1768-1772. (Pubitemid 27164391)
9. Nilsson S, Makela S, Treuter E, Tujague M, Thomsen J, Andersson G, Enmark E, Pettersson K, Warner M, Gustafsson JA: Mechanisms of estrogen action. Physiol Rev 2001;81:1535-1565. (Pubitemid 32951806)
10. Lindner V, Kim SK, Karas RH, Kuiper GG, Gustafsson JA, Mendelsohn ME: Increased expression of estrogen receptor-β mRNA in male blood vessels after vascular injury. Circ Res 1998;83:224-229. (Pubitemid 28354468)
11. Andersson C, Lydrup ML, Ferno M, Idvall I, Gustafsson JA, Nilsson BO: Immunocytochemical demonstration of oestrogen receptor β in blood vessels of the female rat. J Endocrinol 2001;169:241-247. (Pubitemid 32451657)
12. Vegeto E, Belcredito S, Etteri S, Ghisletti S, Brusadelli A, Meda C, Krust A, Dupont S, Ciana P, Chambon P, Maggi A: Estrogen receptor α mediates the brain anti-inflammatory activity of estradiol. Proc Natl Acad Sci USA 2003;100:9614-9619. (Pubitemid 37033976)
13. Li L, Haynes MP, Bender JR: Plasma membrane localization and function of the estrogen receptor α variant (ER46) in human endothelial cells. Proc Natl Acad Sci USA 2003;100:4807-4812. (Pubitemid 36457810)
14. Figtree GA, McDonald D, Watkins H, Channon KM: Truncated estrogen receptor alpha 46-kDa isoform in human endothelial cells: relationship to acute activation of nitric oxide synthase. Circulation 2003;107:120-126. (Pubitemid 36070943)
15. Thomas P, Pang Y, Filardo EJ, Dong J: Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology 2005;146:624-632. (Pubitemid 40129818)
16. Revankar CM, Cimino DF, Sklar LA, Arterburn JB, Prossnitz ER: A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 2005;307:1625-1630. (Pubitemid 40354745)
17. Filardo EJ, Quinn JA, Bland KI, Frackelton AR Jr: Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol Endocrinol 2000;14:1649-1660.
18. Isensee J, Meoli L, Zazzu V, Nabzdyk C, Witt H, Soewarto D, Effertz K, Fuchs H, Gailus- Durner V, Busch D, Adler T, de Angelis MH, Irgang M, Otto C, Noppinger PR: Expression pattern of Gpr30 in LacZ reporter mice. Endocrinology 2009;150:1722-1730.
19. Mårtensson UE, Salehi SA, Windahl S, Gomez MF, Sward K, Daszkiewicz-Nilsson J, Wendt A, Andersson N, Hellstrand P, Grande PO, Owman C, Rosen CJ, Adamo ML, Lundquist I, Rorsman P, Nilsson BO, Ohlsson C, Olde B, Leeb-Lundberg LM: Deletion of the G protein-coupled receptor 30 impairs glucose tolerance, reduces bone growth, increases blood pressure, and eliminates estradiol-stimulated insulin release in female mice. Endocrinology 2009;150:687-698.
20. Olde B, Leeb-Lundberg LM: GPR30/GPER1: searching for a role in estrogen physiology. Trends Endocrinol Metab 2009;20:409-416.
21. Haas E, Bhattacharya I, Brailoiu E, Damjanovic M, Brailoiu GC, Gao X, Mueller-Guerre L, Marjon NA, Gut A, Minotti R, Meyer MR, Amann K, Ammann E, Perez- Dominguez A, Genoni M, Clegg DJ, Dun NJ, Resta TC, Prossnitz ER, Barton M: Regulatory role of G protein-coupled estrogen receptor for vascular function and obesity. Circ Res 2009;104:288-291.
22. Bologa CG, Revankar CM, Young SM, Edwards BS, Arterburn JB, Kiselyov AS, Parker MA, Tkachenko SE, Savchuck NP, Sklar LA, Oprea TI, Prossnitz ER: Virtual and biomolecular screening converge on a selective agonist for GPR30. Nat Chem Biol 2006;2:207-212.
23. Pfaffl MW: A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001;29:e:45.
24. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-275.
25. Odenlund M, Holmqvist B, Baldetorp B, Hellstrand P, Nilsson BO: Polyamine synthesis inhibition induces S phase cell cycle arrest in vascular smooth muscle cells. Amino Acids 2009;36:273-282.
26. Blasko E, Haskell CA, Leung S, Gualtieri G, Halks-Miller M, Mahmoudi M, Dennis MK, Prossnitz ER, Karpus WJ, Horuk R: Beneficial role of the GPR30 agonist G-1 in an animal model of multiple sclerosis. J Neuroimmunol 2009;214:67-77.
27. Ylikomi T, Vienonen A, Ahola T: G protein-coupled receptor 30 down-regulates cofactor expression and interferes with the transcriptional activity of glucocorticoid. Eur J Biochem 2004;271:4159-4168. (Pubitemid 39506744)
28. Teng J, Wang ZY, Prossnitz ER, Bjorling DE: The G protein-coupled receptor GPR30 inhibits human urothelial cell proliferation. Endocrinology 2008;149:4024-4034.
29. Ades EW, Candal FJ, Swerlick RA, George VG, Summers S, Bosse DC, Lawley TJ: HMEC-1: establishment of an immortalized human microvascular endothelial cell line. J Invest Dermatol 1992;99:683-690. (Pubitemid 23002027)
30. Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR: PD098059 is a specific inhibitor of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem 1995;270:27489-27494.
31. Vassale C, Domenici C, Lubrano V, L'Abbate A: Interaction between nitric oxide and cyclooxygenase pathway in endothelial cells. J Vasc Res 2003;40:491-499. (Pubitemid 37465097)
32. Selemidis S, Dusting GJ, Peshavariya H, Kemp-Harper BK, Drummond GR: Nitric oxide suppresses NADPH oxidase-dependent superoxide production by S-nitrosylation in human endothelial cells. Cardiovasc Res 2007;75:349-358. (Pubitemid 46961925)
33. Guo YL, Bai R, Chen CX, Liu DQ, Liu Y, Zhang CY, Zen K: Role of junctional adhesion molecule-like protein in mediating monocyte transendothelial migration. Arterioscler Thromb Vasc Biol 2009;29:75-83.
34. Omidi Y, Campbell L, Barar J, Connell D, Akhtar S, Gumbleton M: Evaluation of the immortalised mouse brain capillary endothelial cell line, b.End3, as an in vitro bloodbrain barrier model for drug uptake transport studies. Brain Res 2003;990:95-112. (Pubitemid 37247600)
35. Brown RC, Morris AP, O'Neil RG: Tight junction protein expression and barrier properties of immortalized mouse brain microvessel endothelial cells. Brain Res 2007;1130:17-30. (Pubitemid 46053886)
36. Bevers, LM, Braam B, Post JA, van Zonneveld AJ, Rabelink TJ, Koomans HA, Verhaar MC, Joles JA: Tetrahydrobiopterin, but not L-arginine, decreases NO synthase uncoupling in cells expressing high levels of endothelial NO synthase. Hypertension 2006;47:87-94. (Pubitemid 43177820)
37. Odenlund M, Ekblad E, Nilsson BO: Stimulation of oestrogen receptor-expressing endothelial cells with oestrogen reduces proliferation of cocultured vascular smooth muscle cells. Clin Exp Pharmacol Physiol 2008;35:245-248. (Pubitemid 351260011)
38. Lindsey SH, Cohen JA, Brosnihan KB, Gallagher PE, Chappell MC: Chronic Treatment with the Gpr30 agonist G-1 decreases blood pressure in ovariectomized Mren2.Lewis rats. Endocrinology 2009;150:3753-3758.
39. Kuhn J, Dina OA, Goswami C, Suckow V, Levine JD, Hucho T: GPR30 estrogen receptor agonists induce mechanical hyperalgesia in the rat. Eur J Neurosci 2008;27:1700-1709. (Pubitemid 351473574)